What do Canadians think about physician–pharmaceutical industry interactions?

Anne Holbrook, Joel Lexchin, Eleanor Pullenayegum, Craig Campbell, Bernard Marlow, Sue Troyan, Charles Weijer, Jeff Blackmer, Kevin Brazil and Don Willison

Health Policy, 2013, vol. 112, issue 3, 255-263

Abstract: Many health professional and regulatory groups have guidelines for identifying, disclosing and managing potential conflicts of interest (COI). The opinions of the Canadian public regarding what constitutes COI are unknown.

Keywords: Conflict of interest; Public opinion survey; Physician–pharmaceutical industry interactions; Drug policy (search for similar items in EconPapers)
Date: 2013
References: View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851013001176
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:112:y:2013:i:3:p:255-263

DOI: 10.1016/j.healthpol.2013.04.020

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().